GENETX BIOTHERAPEUTICS
GeneTx Biotherapeutics is a biotechnology company focusing on developing therapeutics for the treatment of Angelman syndrome. It also offers an antisense therapy for treating the rare genetic disorder that causes developmental delay, impaired motor function, loss of speech, and epilepsy. Founded in 2017, GeneTx Biotherapeutics is headquartered in Downers Grove, Illinois.
GENETX BIOTHERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2017-12-01
Address:
Downers Grove, Illinois, United States
Country:
United States
Website Url:
http://www.genetxbio.com
Total Employee:
11+
Status:
Active
Contact:
(630) 639-7271
Total Funding:
6.32 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.genetxbio.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.94 K
- Host name: 104.21.49.36
- IP address: 104.21.49.36
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GeneTx Biotherapeutics"
GeneTx and Ultragenyx Receive Clearance from Health Canada
May 19, 2021 GeneTx was launched by FAST, a patient advocacy organization and the largest non-governmental funder of Angelman syndrome research. GeneTx licensed the rights to โฆSee details»
GeneTx Biotherapeutics - Crunchbase Company Profile & Funding
GeneTx Biotherapeutics is a biotechnology company focusing on developing therapeutics for the treatment of Angelman syndrome. It also offers an antisense therapy for treating the rare โฆSee details»
GeneTx Biotherapeutics - Overview, News & Similar companies
Dec 1, 2021 GeneTx and Ultragenyx Provide Preliminary Update on Phase 1/2 Clinical Study of GTX-102 in Canada and U.K. Patients with Angelman Syndrome SARASOTA, Fla. and โฆSee details»
GenEditBio
GenEditBio are working with efficient, versatile and safe gene editing tools which have distinct gene editing and targeting capabilities. Using these tools, we can access a broad range of โฆSee details»
MATERIAL SAFETY DATA SHEET - genetbio.com
Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 E-mail: [email protected] URL: www.genetbio.com MATERIAL SAFETY DATA SHEET Section 1-Product and Company โฆSee details»
GenEditBio - Crunchbase Company Profile & Funding
GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.See details»
GentiBio - LinkedIn
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed โฆSee details»
History | ์ ๋ท๋ฐ์ด์ค - genetbio.com
GenetBio Workshop (Prague) 2018. Participated in India Lab Expo 2018 conference; Venture company Reaccreditation; Genet Bio Workshop (Saipan) 2017. Selected as a technology โฆSee details»
GeneDx | Clinical Genomics | Genetic Testing | Rapid Results
GeneDx is a leader in clinical genomics and rare disease. Read about our unparalleled database, deep clinical knowledge and expertise in variant interpretation.See details»
GeneTx and Ultragenyx Announce First Patient Dosed in
Oct 7, 2021 GeneTx was launched by FAST, a patient advocacy organization and the largest non-governmental funder of Angelman syndrome research. GeneTx licensed the rights to โฆSee details»
GeneDx - Wikipedia
GeneDx is a genetic testing company that was founded in 2000 by two scientists from the National Institutes of Health (NIH), Sherri Bale and John Compton. [1] [2] [3 ...See details»
MATERIAL SAFETY DATA SHEET - genetbio.com
Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 E-mail: [email protected] URL: www.genetbio.com Manufacturer's Label Number: Date of Label: Year Procured: N/K โฆSee details»
How Genetic Testing Works - GeneDx
Hereโs what to expect during the genetic testing process: Next steps Access educational resources, billing details, and GeneDx support. Learn more about the benefits of exome and โฆSee details»
GeneTx and Ultragenyx Announce First Patient Dosed in Canada in โฆ
SARASOTA, Fla. and NOVATO, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), companies โฆSee details»
Made by ISO 9001 & ISO 13485 system Prime Taq Premix (2X)
GENETBIO Inc. Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 e-mail: [email protected] homepage: www.genetbio.com Prime Taq Prem. ix (2X) Cat. No. Size ; Remark ; G-2000 1 ml โฆSee details»
Science & Research - GeneDx
With advanced genomic technologies, our rich internal database, and extensive clinical expertise, GeneDxโs industry-leading tests deliver clinically actionable results, faster.See details»
Made by Prime Taq DNA Polymerase - genetbio.com
GENETBIO Inc. Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 e-mail: [email protected] homepage: www.genetbio.com Prime Taq DNA Polymerase Cat. No. Size 3. Remark G-1000 โฆSee details»
RT PCR Kit RT PCR Premix (2X) - genetbio.co.kr
GENETBIO Inc. Tel.: 1599-4003, 0502-523-3484 Fax.: 0502-523-3485 e-mail: [email protected] homepage: www.genetbio.com SuPrimeScript. RT-PCR Kit SuPrim. โฆSee details»
ExPrime Taq Premix (2X) - genetbio.com
GENETBIO Inc. Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 e-mail: [email protected] homepage: www.genetbio.com ExPrim. e Taq Prem. ix (2X) Cat. No. Size Remark G-5000 1 โฆSee details»
MATERIAL SAFETY DATA SHEET - genetbio.com
GENETBIO Inc. Tel.: +82-0502-523-3484 Fax.: +82-0502-523-3485 E-mail: [email protected] URL: www.genetbio.com Material Safety Data Sheet SECTION 1. Identification Product โฆSee details»